Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Bereskin & Parr LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Bereskin & Parr LLP

arrow
Coatings Trends
Not Confirmed

Bereskin & Parr LLP

Country
arrow
Coatings Trends
Not Confirmed

INFIGRATINIB

Brand Name : TRUSELTIQ

Patent Number : 2570873

Filing Date : 2005-06-23

Strength per Unit : 50 mg / dose

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-06-23

Date Granted : 2014-04-29

blank

02

Bereskin & Parr LLP

arrow
Coatings Trends
Not Confirmed

Bereskin & Parr LLP

Country
arrow
Coatings Trends
Not Confirmed

INFIGRATINIB

Brand Name : TRUSELTIQ

Patent Number : 2781431

Filing Date : 2010-12-06

Strength per Unit : 50 mg / dose

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-12-06

Date Granted : 2017-10-31

blank

03

Bereskin & Parr LLP

arrow
Coatings Trends
Not Confirmed

Bereskin & Parr LLP

Country
arrow
Coatings Trends
Not Confirmed

INFIGRATINIB

Brand Name : TRUSELTIQ

Patent Number : 2570873

Filing Date : 2005-06-23

Strength per Unit : 75 mg / dose

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-06-23

Date Granted : 2014-04-29

blank

04

Bereskin & Parr LLP

arrow
Coatings Trends
Not Confirmed

Bereskin & Parr LLP

Country
arrow
Coatings Trends
Not Confirmed

INFIGRATINIB

Brand Name : TRUSELTIQ

Patent Number : 2781431

Filing Date : 2010-12-06

Strength per Unit : 75 mg / dose

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-12-06

Date Granted : 2017-10-31

blank

05

Bereskin & Parr LLP

arrow
Coatings Trends
Not Confirmed

Bereskin & Parr LLP

Country
arrow
Coatings Trends
Not Confirmed

INFIGRATINIB

Brand Name : TRUSELTIQ

Patent Number : 2570873

Filing Date : 2005-06-23

Strength per Unit : 100 mg / dose

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-06-23

Date Granted : 2014-04-29

blank

06

Bereskin & Parr LLP

arrow
Coatings Trends
Not Confirmed

Bereskin & Parr LLP

Country
arrow
Coatings Trends
Not Confirmed

INFIGRATINIB

Brand Name : TRUSELTIQ

Patent Number : 2781431

Filing Date : 2010-12-06

Strength per Unit : 100 mg / dose

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-12-06

Date Granted : 2017-10-31

blank

07

Bereskin & Parr LLP

arrow
Coatings Trends
Not Confirmed

Bereskin & Parr LLP

Country
arrow
Coatings Trends
Not Confirmed

INFIGRATINIB

Brand Name : TRUSELTIQ

Patent Number : 2570873

Filing Date : 2005-06-23

Strength per Unit : 125 mg / dose

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-06-23

Date Granted : 2014-04-29

blank

08

Bereskin & Parr LLP

arrow
Coatings Trends
Not Confirmed

Bereskin & Parr LLP

Country
arrow
Coatings Trends
Not Confirmed

INFIGRATINIB

Brand Name : TRUSELTIQ

Patent Number : 2781431

Filing Date : 2010-12-06

Strength per Unit : 125 mg / dose

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-12-06

Date Granted : 2017-10-31

blank